Advances in the Scientific Evaluation of Bladder Cancer and Molecular Basis for Diagnosis and Treatment

Abstract

Bladder cancer is the sixth most common cancer in the world affecting more than 300,000 men and women worldwide. This book summarizes the vast breadth of current understanding of the molecular and genetic processes involved in carcinogenesis of the bladder, carcinoma in-situ and treatment modalities of muscle invasive disease, immune-therapy and potential targets for future therapy.